Literature DB >> 20625804

Pulmonary vein isolation using a compliant endoscopic laser balloon ablation system in a swine model.

Edward P Gerstenfeld1, John Michele.   

Abstract

INTRODUCTION: The incidence of pulmonary vein reconnection and recurrent atrial fibrillation after a single catheter ablation procedure is unacceptably high. We studied the ability of a novel endoscopic laser balloon ablation system (EAS) to achieve acute and chronic pulmonary vein (PV) isolation in a swine model.
METHODS: Eight swine underwent EAS ablation and two underwent standard radiofrequency ablation for comparison. In the EAS arm, laser energy was delivered under visual guidance around the PV antrum in overlapping 30-degree arcs. In the standard ablation arm, radiofrequency energy was delivered via a 4-mm-tip catheter. PV isolation was confirmed acutely after 30 min, and reassessed after 4-6 weeks. Animals were then sacrificed for histopathologic analysis of the PVs.
RESULTS: For the EAS animals, 44 ± 10 overlapping lesions were required to achieve acute RSPV isolation. Chronic PV isolation was documented with the circular mapping catheter a mean of 28 ± 9 days after ablation in 7/8 animals (83%). In the standard ablation arm, 30 ± 3 RF lesions were delivered to achieve acute PV isolation. There was evidence of PV reconnection in both animals during the chronic study. Histologically, completely transmural circumferential lesions were found in 7/8 EAS animals, with 99% circumferentiality in the remaining animal. Both control RF animals had evidence of gaps, with isolation of 90% and 75% of the targeted PV segments, respectively.
CONCLUSION: Visually guided laser ablation using light energy via a compliant balloon catheter is feasible and achieved chronic isolation in 83% of targeted PVs.

Entities:  

Mesh:

Year:  2010        PMID: 20625804     DOI: 10.1007/s10840-010-9501-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

1.  Long-term single procedure efficacy of catheter ablation of atrial fibrillation.

Authors:  Aamir Cheema; Chandrasekhar R Vasamreddy; Darshan Dalal; Joseph E Marine; Jun Dong; Charles A Henrikson; David Spragg; Alan Cheng; Saman Nazarian; Sunil Sinha; Henry Halperin; Ronald Berger; Hugh Calkins
Journal:  J Interv Card Electrophysiol       Date:  2006-08-05       Impact factor: 1.900

2.  Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation.

Authors:  Kristina Lemola; Burr Hall; Peter Cheung; Eric Good; Jihn Han; Kamala Tamirisa; Aman Chugh; Frank Bogun; Frank Pelosi; Fred Morady; Hakan Oral
Journal:  Heart Rhythm       Date:  2004-07       Impact factor: 6.343

3.  Incidence and predictors of very late recurrence of atrial fibrillation after ablation.

Authors:  Sumeet K Mainigi; William H Sauer; Joshua M Cooper; Sanjay Dixit; Edward P Gerstenfeld; David J Callans; Andrea M Russo; Ralph J Verdino; David Lin; Erica S Zado; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-11-01

4.  Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Erica Zado; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

5.  Efficacy and safety of targeted focal ablation versus PV isolation assisted by magnetic electroanatomic mapping.

Authors:  Francis E Marchlinski; David Callans; Sanjay Dixit; Edward P Gerstenfeld; Robert Rho; Jian-Fang Ren; Erica Zado
Journal:  J Cardiovasc Electrophysiol       Date:  2003-04

6.  Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation.

Authors:  Aamir Cheema; Jun Dong; Darshan Dalal; Joseph E Marine; Charles A Henrikson; David Spragg; Alan Cheng; Saman Nazarian; Kenneth Bilchick; Sunil Sinha; Daniel Scherr; Ibrahim Almasry; Henry Halperin; Ronald Berger; Hugh Calkins
Journal:  J Cardiovasc Electrophysiol       Date:  2007-04

7.  Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.

Authors:  Carlo Pappone; Hakan Oral; Vincenzo Santinelli; Gabriele Vicedomini; Christopher C Lang; Francesco Manguso; Lucia Torracca; Stefano Benussi; Ottavio Alfieri; Robert Hong; William Lau; Kirk Hirata; Neil Shikuma; Burr Hall; Fred Morady
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

8.  "Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation.

Authors:  Thomas Arentz; Laurent Macle; Dietrich Kalusche; Mélèze Hocini; Pierre Jais; Dipen Shah; Michel Haissaguerre
Journal:  J Cardiovasc Electrophysiol       Date:  2004-09

9.  Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation.

Authors:  David J Callans; Edward P Gerstenfeld; Sanjay Dixit; Erica Zado; Mark Vanderhoff; Jian-Fang Ren; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2004-09

10.  Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome.

Authors:  Vivek Y Reddy; Petr Neuzil; Sakis Themistoclakis; Stephan B Danik; Aldo Bonso; Antonio Rossillo; Antonio Raviele; Robert Schweikert; Sabine Ernst; Karl-Heinz Kuck; Andrea Natale
Journal:  Circulation       Date:  2009-06-22       Impact factor: 29.690

  10 in total
  2 in total

1.  Three-dimensional Rotational Angiography as a Periprocedural Imaging Tool in Atrial Fibrillation Ablation.

Authors:  Tom De Potter; Gazmend Bardhaj; Aniello Viggiano; Keith Morrice; Peter Geelen
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-11-29

2.  In situ optical mapping of voltage and calcium in the heart.

Authors:  Peter Lee; Fouad Taghavi; Ping Yan; Paul Ewart; Euan A Ashley; Leslie M Loew; Peter Kohl; Christian Bollensdorff; Christopher E Woods
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.